A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

  • Sabanathan, Dhanusha, (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Chapman, Nicola, (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymZN-c5-002
StatusActive
Effective start/end date15/10/2014/10/25